CANCER GENETICS

CGIX NASDAQ
0.1078
-0.0022
-1.98%
After Hours: 0.1084 +0.0006 +0.54% 16:23 08/23 EDT
Open
0.1149
Prev Close
0.1100
High
0.1150
Low
0.1060
Volume
1.63M
Avg Vol (3M)
1.88M
52 Week High
1.300
52 Week Low
0.1045
% Turnover
2.70%
Market Cap
6.51M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers CANCER GENETICS CGIX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Cancer Genetics, Inc. is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services and molecular markers. Through its subsidiary, the Company offers preclinical test systems. The Company offers discovery services to the pharmaceutical industry, biotechnology companies and academic research centers. The Company provides the tools and testing methods for companies and researchers to identify new molecular- and biomarker-based indicators for disease and to determine the pharmacogenomics, toxicity and efficacy of therapeutic candidate compounds. Its discovery services include development of both xenograft and syngeneic animal models, toxicology and genetic toxicology services, pharmacology testing, pathology services, and validation of biomarkers for diseases including cancers. It also provides consulting, guidance and preparation of samples.
MORE >

Recently

Name
Price
%Change